medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2001, Number 3

<< Back Next >>

Rev Biomed 2001; 12 (3)

Chlamydia trachomatis infection in pregnant women with premature membrane rupture or premature delivery threat.

Ramos-Zepeda R, Pérez-Medina R, Barba-Barajas M, Palma-Ramírez T, Flores-García A, Garibaldi-Becerra V, Carranco-López A, Bravo-Cuéllar A

Language: English
References: 52
Page: 158-165
PDF size: 42.71 Kb.


ABSTRACT

Introduction. Chlamydia trachomatis is considered the causal agent of trachoma, salpingitis, endometritis, and may be involved in premature membrane rupture (PMR) and premature delivery threat (PDT). The aim of this work was to determine the presence of C. trachomatis antigens and antibodies against C. trachomatis in pregnant women with PMR, PDT or normal pregnancy (NP). Material and methods. We took endocervical samples from 50 pregnant women of each group for determination of C. trachomatis antigens by means of an direct immunofluorescence method; additionally, 5 mL of peripheral blood were taken to identify anti-C. trachomatis antibodies by indirect immunoflurescence assay. Results. Six per cent (3/50) of PMR patients showed C. trachomatis antigens and IgG anti-C. trachomatis antibodies. Two per cent (1/50) of PDT patients had C. trachomatis and IgM anti-C. trachomatis antibodies. Six per cent (3/50) of NP patients exhibited antigens C. trachomatis but no anti-C. trachomatis antibodies. Moreover, only IgG anti-C. trachomatis antibodies were found respectively in 10% (5/50), 10% (5/50) and 16% (8/50) of the PMR, PDT and NP women groups. Conclusions. The finding of C. trachomatis antigens as well as anti-C. trachomatis antibodies in the three studied groups, emphasizes the importance of an opportune identification of the infection in order to apply the adequate treatment and prevent sequelae in both the pregnant women and their products.


REFERENCES

  1. Center for Disease Control and Prevention: Recomendations for the prevention and manegement of Chlamydia trachomatis infections. MMWR 1993; 42:1-41.

  2. Schachter J, Jones RB, Butler RC, Rice B, Brooks D, van der Pol B, et al. Evaluation of the Vidas Chlamydia Test to detect and verify Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1997; 35:2102-06.

  3. Suchland KL, Counts JM, Stamm WE. Laboratory methods for detection of Chlamydia trachomatis: Survey of laboratories in Washington State. J Clin Microbiol 1997; 35:3210-14.

  4. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P. Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177:417-24.

  5. Narcio-Reyes ML, Solórzano-Santos F, Arredondo- García JL, Calderón-Jaimes E, Beltrán-Zúñiga M. Etiología de la infección cérvicovaginal en pacientes embarazadas y no embarazadas. Ginec Obstet Mex 1989; 57:41-6.

  6. Guerra-Infante F, Flores-Medina S, López-Hurtado M, Sosa-González IE, Arredondo-García JL. Evaluación de la sensibilidad y especificidad de tres reactivos de inmunofluorescencia directa para el diagnóstico de Chlamydia trachomatis. Ginec Obstet Mex 1994; 63:368-73.

  7. Bustos-López H, Barrón-Vallejo J, García-Malváez B, Kably-Ambe A, Cáceres-Zelaya H. Aplicación de un algoritmo diagnóstico prospectivo para pacientes con pérdida fetal recurrente. Ginec Obstet Mex 1995; 63:96-101.

  8. Bustos-López HH, Vázquez-Juárez ME, Arredondo- García JL, Lira-Plascencia J, Beltrán-Zúñiga M, Guerra- Infante F. Prevalencia de Chlamydia trachomatis en pacientes con esterilidad y embarazos no complicados. Perinatol Reprod Hum 1995; 9:227-34.

  9. Acosta-Cázares B. Chlamydia trachomatis como factor de riesgo de algunas complicaciones del embarazo. Enf Infec Microbiol 1996; 16:142-5.

  10. Díaz-Barreiro G, Díaz-López E, Servín-Ramírez JF. Frecuencia de Chlamydia trachomatis en el cérvix de pacientes embarazadas en control prenatal. Ginec Obstet Mex 1997; 65:48-51.

  11. Pastorek II JG. Infections during pregnancy. Clin Obst Gynecol 1993; 4:793.

  12. Scott JR. Recurrent miscarriage Overview and recomendations. Clin Obstet Gynecol 1994; 37: 768-73.

  13. Numazaki K, Kusaka T, Chiba S. Perinatal complications are associated with seropositivity to Chlamydia trachomatis during pregnancy. Clin Infect Dis 1996; 23:208.

  14. Bajares M. Infecciones ginecológicas por Clamidia. Rev Obstet Ginecol Venez 1996; 56:S11-16.

  15. Carey JC, Yaffe SJ, Catz C. The vaginal infections and prematurity study: An review. Clin Obstet Gynecol 1993; 36:809-20.

  16. Holst E, Goffeng AR, Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol 1994; 32:176-86.

  17. Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, et al. Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infec Dis 1995; 21:424-6.

  18. Nadisauskiene R, Bergström S, Stankeviciene I, Spukaite T. Endocervical pathogens in women with preterm and term labour. Gynecol Obstet Invest 1995; 40:179-82.

  19. West SK, Muñoz B, Lynch M, Kayongoya A, Mmbaga BBO, Taylor HR. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol 1996; 143:73-8.

  20. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-7.

  21. Tasdemir I, Tasdemir M, Kodama H, Sekine K, Tanaka T. Relationship of chlamydial infection to male infertility: Sperm parameters/antisperm antibodies. Arch STD/HIV Res 1995; 9:13-7.

  22. Mehanna MTR, Rizk MA, Eweiss NYM, Ramadan M, Zaki SA, Sadek A, et al. Chlamydial serology among patients with tubal factor infertility and ectopic pregnancy in Alexandria, Egypt. Sex Transm Dis 1995; 22:317-21.

  23. Witkin SS, Ledger WJ. Antibodies to Chlamydia trachomatis in sera of women with recurrent spontaneous abortions. Am J Obstet Gynecol 1992; 167:135-9.

  24. Shuland RJ, Rockey DD, Bannantine JP, Stamm WE. Isolates of Chlamydia trachomatis that occupy nonfusogenic iclusions lack incA, a protein localized to the inclusion membrane. Infect Immun 2000; 68:360-7

  25. Ghaem-Maghami S, Bailey RL, Mabey DCW, Hay PE, Mahdi OSM, Joof HM, et al. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infec Immun 1997; 65:4958-64.

  26. Faro S. Chlamydia trachomatis: Female pelvic infection. Am J Obstet Gynecol 1991; 164:1767-70.

  27. Kimani J, Maclean IW, Bwayo JJ, MacDonald K, Oyugi J, Maitha GM, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infec Dis 1996; 173:1437-44.

  28. Toye B, Laferrière C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heatshock protein and tubal infertility. J Infec Dis 1993; 168:1236-40.

  29. Toye B, Peeling RW, Jessamine P, Claman P, Gemmill I. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol 1996; 34:1396-400.

  30. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA. Pooling urine sample for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998; 36:481-5.

  31. Pate MS, Ed M, Hook III EW. Laboratory to laboratory variation in Chlamydia trachomatis culture practices. Sex Transm Dis 1995; 22:322-6.

  32. Dean D, Ferrero D, McCarthy M. Comparison of performance and cost-effectiveness of direct fluorescentantibody, ligase chain reaction, and PCR assay for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection. J Clin Microbiol 1998; 36:94-9.

  33. Chan EL, Brandt K, Horsman G. Evaluation of Sanofi Diagnostics Pasteur Chlamydia Microplate EIA shortened assay and comparison with cell culture and Syva Chlamydia MicroTrak II EIA in high- and low-risk populations. J Clin Microbiol 1995; 33:2839-41.

  34. Hook EW, Smith K, Mullen C, Stephens J, Rinehardt L, Pate MS, Lee HH. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997; 35:2133-5.

  35. Puolakkainen M, Hiltunen-Back E, Reunala T, Suhonen S, Lähteenmäki P, Lehtinen M, et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998; 36:1489-93.

  36. Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998; 36:1630-3.

  37. Morré SA, Ossewaarde JM, Lan J, van Doornum GJJ, Walboomers JMM, MacLaren DM, et al. Serotyping and genotyping of genital Chlamydia trachomatis isolats reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol 1998; 36:345-51.

  38. Lin JSL, Donegan SP, Heeren TC, Greenberg M, Flaherty EE, et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998; 178:1707-12.

  39. Numazaki K, Niida Y, Chiba S. Antigen detection of Chlamydia trachomatis from the endocervix is not enough for screening of perinatal complications. Am J Obstet Gynecol 1997; 176:951-2.

  40. van der Pol B, Williams JA, Jones RB. Rapid antigen detection assay for identification of Chlamydia trachomatis infection. J Clin Microbiol 1995; 33:1920-1.

  41. Goessens WHF, Mouton JW, van der Meijden WI, Deelen S, van Rijsoort-Vos TH, Lemmens-den TN, et al. Comparison of three comercially available amplification assays, AMP CT, LCx, and Cobas Amplicor, for detection of Chlamydia trachomatis in first –void urine. J Clin Microbiol 1997; 35:2628-33.

  42. Lauderdale TL, Landers L, Thorneycroft I, Chapin K. Comparison of the PACE 2 assay, two amplification asays, and clearview EIA for detection of Chlamydia trachomatis in famele endocervical and urine specimens. J Clin Microbiol. 1999; 37:2223-9.

  43. Stam WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis 1999; 179: S380-3.

  44. Green TA, Black CM, Johnson RE. Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis. J Clin Microbiol 1998; 36:375-81.

  45. Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the gen-probe amplified Chlamydia trachomatis assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998; 36:391-4.

  46. Fong CKY, Falcone J, Landry ML. Use of a single swab in multi-microbe or flex trans transport medium for detection of Chlamydia trachomatis by Roche Amplicor PCR and culture in specimens for two different patient populations. J Clin Microbiol 1997; 35:2427-9.

  47. Peeling RW, Bailey RL, Conway DJ, Holland MJ, Campbell AE, Jallow O, et al. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis 1998; 177:256-9.

  48. Chan EL, Brandt K, Horsman GB. A 1-year evaluation of Syva Micro Trak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in high-volume laboratory. J Clin Microbiol 1994; 32:2208-11.

  49. Haddix AC, Hillis SD, Kassler WJ, The cost effectiveness of azithromicyn for Chlamydia trachomatis infections in women. Sex Transm Dis 1995; 22:274-80.

  50. Johnson AM, Grun L, Haines A. Control de la infección genital por Chlamydia. BMJ 1997; 5:9-11.

  51. Kapala J, Copes D, Sproston A, Patel J, Jang D, Petrich A, et al. Pooling cervical swabs and testing by ligase chain reaction are accurate and diagnosis of Chlamydia trachomatis. J Clin Microbiol 2000; 2480-3.

  52. VanDerpol B, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia thrachomatis. J Clin Microbiol 2000; 38:1105-12.




2020     |     www.medigraphic.com